1 |
FURIN J,COX H,PAI M.Tuberculosis[J].Lancet,2019,393(10181):1642-1656.
|
2 |
PAI M, KASAEVA T, SWAMINATHAN S. Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery[J]. N Engl J Med,2022.
|
3 |
王辉,马筱玲,钱渊,等. 主译.临床微生物学手册(第12版第1卷)[M]. 北京:中华医学电子音像出版社,2021:560-576.
|
4 |
SABIN S, HERBIG A, VÅGENE Å J,et al. A seventeenth-century Mycobacterium tuberculosis genome supports a Neolithic emergence of the Mycobacterium tuberculosis complex[J]. Genome Biol,2020,21(1):201.
|
5 |
FRESCHI L, VARGAS R, HUSAIN A,et al. Population structure, biogeography and transmissi- bility of Mycobacterium tuberculosis[J]. Nat Commun,2021,12(1):6099.
|
6 |
ERNST J D. Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design[J]. Cell Host Microbe,2018,24(1):34-42.
|
7 |
GYGLI S M, BORRELL S, TRAUNER A,et al. Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives[J]. FEMS Microbiol Rev,2017,41(3): 354-373.
|
8 |
MELSEW Y A, DOAN T N, GAMBHIR M,et al. Risk factors for infectiousness of patients with tuberculosis: a systematic review and meta-analysis[J]. Epidemiol Infect,2018,146(3): 345-353.
|
9 |
URBANOWSKI M E, ORDONEZ A A, RUIZ-BEDOYA C A,et al. Cavitary tuberculosis: the gateway of disease transmission[J].Lancet Infect Dis, 2020,20(6):e117-e128.
|
10 |
O'SHEA M K, KOH G C, MUNANG M,et al. Time-to-detection in culture predicts risk of Mycobacterium tuberculosis transmission: a cohort study[J]. Clin Infect Dis,2014,59(2): 177-185.
|
11 |
PATTERSON B, WOOD R. Is cough really necessary for TB transmission?[J].Tuberculosis (Edinb),2019,117:31-35.
|
12 |
WURIE F B, LAWN S D, BOOTH H,et al. Bioaerosol production by patients with tuberculosis during normal tidal breathing: implications for transmission risk[J]. Thorax,2016,71(6): 549-554.
|
13 |
DONALD P R, DIACON A H, LANGE C,et al. Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research,1878-1940[J].Int J Tuberc Lung Dis,2018,22(9): 972-982.
|
14 |
STITI M, CASTANET G, CORBE A,et al. Transition from saliva droplets to solid aerosols in the context of COVID-19 spreading[J].Environ Res,2022204(Pt B):112072.
|
15 |
FENNELLY K P. Particle sizes of infectious aerosols: implications for infection control[J]. Lancet Respir Med,2020,8(9):914-924.
|
16 |
SCHIJVEN J, VERMEULEN L C, SWART A,et al. Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing[J]. Environ Health Perspect,2021,129(4):47002.
|
17 |
DINKELE R, GESSNER S, MCKERRY A,et al. Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols[J].PLoS Pathog,2021,17(2): e1009262.
|
18 |
PATTERSON B, WOOD R. Is cough really necessary for TB transmission?[J]Tuberculosis (Edinb),2019,117:31-35.
|
19 |
JONES-LÓPEZ E C, ACUÑA-VILLAORDUÑA C, SSEBIDANDI M,et al. Cough Aerosols of Mycobacterium tuberculosis in the Prediction of Incident Tuberculosis Disease in Household Contacts[J]. Clin Infect Dis,2016,63(1):10-20.
|
20 |
MARTINEZ L, VERMA R, CRODA J,et al. Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: a review of the evidence and epidemiological implications[J].Eur Respir J,2019,53(6):1802302.
|
21 |
ZUMLA A, YEBOAH-MANU D, MICHEL A L,et al. Zoonotic tuberculosis-a call for an open One Health debate[J]. Lancet Infect Dis,2020,20(6):642-644.
|
22 |
DEAN A S, FORCELLA S, OLEA-POPELKA F,et al. A roadmap for zoonotic tuberculosis: a One Health approach to ending tuberculosis[J]. Lancet Infect Dis,2018,18(2):137-138.
|
23 |
BUSS B F, KEYSER-METOBO A, ROTHER J,et al. Possible Airborne Person-to-Person Transmission of Mycobacterium bovis - Nebraska 2014-2015[J]. MMWR Morb Mortal Wkly Rep,2016, 65(8):197-201.
|
24 |
BERG S, SMITH N H. Why doesn't bovine tuberculosis transmit between humans?[J]. Trends Microbiol,2014,22(10):552-553.
|
25 |
HOUBEN R M, DODD P J. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling[J]. PLoS Med,2016,13(10):e1002152.
|
26 |
CAMPBELL J R, WINTERS N, MENZIES D. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis[J]. BMJ,2020,368:m549.
|
27 |
BJORN-MORTENSEN K, LILLEBAEK T, KOCH A,et al. Extent of transmission captured by contact tracing in a tuberculosis high endemic setting[J]. Eur Respir J,2017,49(3):1601851.
|
28 |
ACUÑA-VILLAORDUÑA C, JONES-LÓPEZ E C, FREGONA G,et al. Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease[J]. Eur Respir J,2018, 51(1):1701578.
|
29 |
MARTINEZ L, CORDS O, HORSBURGH C R,et al. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis[J]. Lancet,2020, 395(10228):973-984.
|
30 |
LUZZATI R, MIGLIORI G B, ZIGNOL M,et al. Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker[J]. Eur Respir J,2017,50(5):1701414.
|
31 |
MAYNARD-SMITH L, BROWN C S, HARRIS R J,et al. Effectiveness and outcomes of air travel- related TB incident follow-up: a systematic review[J]. Eur Respir J,2021,57(5):2000013.
|
32 |
SCRIBA T J, FIORE-GARTLAND A, PENN-NICHOLSON A,et al. Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial[J]. Lancet Infect Dis,2021, 21(3):354-365.
|
33 |
SHAH M, DORMAN S E. Latent Tuberculosis Infection[J]. N Engl J Med,2021,385(24):2271-2280.
|
34 |
KNIGHT G M, MCQUAID C F, DODD P J,et al. Global burden of latent multidrug-resistant tuberculosis:trends and estimates based on mathematical modelling[J]. Lancet Infect Dis, 2019,19(8):903-912.
|